Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DAVE | CRC |
|---|---|---|
| Price | $368.94 | $53.01 |
| Change today | ▲ 6.45% | ▲ 1.11% |
| Market cap | $4.71B | $4.71B |
| Return, 3 months | -3.9% | +4.6% |
| Return, year to date | +66.6% | +21.1% |
| Return, 1 year | +84.2% | +4.6% |
| P/E (TTM) | 23.8 | -42.4 |
| P/B | 22.6 | 1.4 |
| P/E percentile vs own 5y | – | 2nd |
| Dividend yield | – | 3.02% |
| Revenue growth (YoY, latest qtr) | +59.7% | – |
| Net profit growth (YoY) | +238.4% | – |
| Gross margin | 86.7% | – |
| Operating margin | 33.7% | – |
| Net margin | 35.3% | – |
| Return on equity | – | – |
| Analyst target vs. price | +23.5% | +45.0% |
| Analyst buy share | 92% | 100% |
| RSI (14) | 57 | 50 |
| 30-day volatility | 63.5% | 28.9% |
| Max drawdown, 1 year | -39.1% | -29.2% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
